
Lind is a precision trial matching platform that connects patients and innovators through intuitive interfaces and advanced AI—at exceptional speed and scale. The company focuses on providing accurate and fast trial matching, enabling patients to find suitable clinical trials based on their medical history. With over 85,000 active clinical trials and 1,200 enrolling medical centers, Lind aims to streamline the trial enrollment process and improve patient care through data-driven insights and optimized trial designs.

Lind is a precision trial matching platform that connects patients and innovators through intuitive interfaces and advanced AI—at exceptional speed and scale. The company focuses on providing accurate and fast trial matching, enabling patients to find suitable clinical trials based on their medical history. With over 85,000 active clinical trials and 1,200 enrolling medical centers, Lind aims to streamline the trial enrollment process and improve patient care through data-driven insights and optimized trial designs.
What they do: AI-powered clinical trial matching that analyzes EHRs and protocols to produce evidence-linked eligibility assessments
Size & HQ: San Mateo, CA; ~1–10 employees
Data coverage: Indexes 85,000+ active clinical trials and 1,200 enrolling medical centers
Funding signal: Raised at least two rounds; investors include CancerX Startup Accelerator and 8VC
Clinical trial recruitment and eligibility screening
Healthtech / Clinical trials
Most recent round type listed as Non-equity Assistance (per company financial summaries)
“Backed by CancerX Startup Accelerator and 8VC”